ENZN·293904108·US·equity·Healthcare - Biotechnology-Activist
ENZN (Enzon Pharmaceuticals Inc) is held by 0 institutional investors as of Q2 2020.
See how ENZN's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer